Kamada (KMDA) Change in Working Capital (2012 - 2026)

Kamada (KMDA) posted quarterly Change in Working Capital of -$12.1 million for Q1 2026, up 2.5% year-on-year from -$11.8 million in Q1 2025, and down 379.26% on a QoQ basis from $4.3 million in Q4 2025.

Kamada (KMDA) Change in Working Capital (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Change in Working Capital for 15 consecutive years, with -$12.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Working Capital rose 2.5% year-over-year to -$12.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.5 million (down 217.0% YoY) and the FY2025 annual result came in at -$17.7 million, down 186.96% from the prior year.
  • Change in Working Capital fell to -$12.1 million in Q1 2026 per KMDA's latest filing, from $4.3 million in the prior quarter.
  • Over the last five years, Change in Working Capital for KMDA reached as high as $13.0 million in Q3 2024 and fell as low as -$12.4 million in Q1 2025.
  • A 5-year average of -$295901.7 and a median of -$314.0 in 2022 frame the typical range for Change in Working Capital.
  • The largest YoY upside for Change in Working Capital was 30558.29% in 2023 against a maximum downside of 2048944.59% in 2023.
  • Year by year, Change in Working Capital stood at $4299.0 in 2022, then surged by 30558.29% to $1.3 million in 2023, then soared by 324.13% to $5.6 million in 2024, then retreated by 22.36% to $4.3 million in 2025, then sank by 379.26% to -$12.1 million in 2026.
  • According to Business Quant data, Change in Working Capital over the past three periods registered -$12.1 million, $4.3 million, and -$1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -617.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn -12.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.12 Mn
Mar 31, 2026 -12.12 Mn
Dec 31, 2025 4.34 Mn
Dec 31, 2025 4.34 Mn
Sep 30, 2025 -1.55 Mn
Sep 30, 2025 -1.55 Mn
Jun 30, 2025 -3.22 Mn
Jun 30, 2025 -3.22 Mn
Mar 31, 2025 -12.43 Mn
Mar 31, 2025 -12.43 Mn
Dec 31, 2024 5.59 Mn
Dec 31, 2024 5.59 Mn
Sep 30, 2024 13.01 Mn
Sep 30, 2024 13.01 Mn
Jun 30, 2024 4.56 Mn
Jun 30, 2024 4.56 Mn
Mar 31, 2024 -6.62 Mn
Mar 31, 2024 -6.62 Mn
Dec 31, 2023 1.32 Mn
Dec 31, 2023 1.32 Mn